To investigate the association between the loss of MGMT expression and the clinicopathologic characteristics, we carried out immunohistochemistry using six tissue array blocks containing 315 consecutive gastric carcinomas with the follow-up data. The gene discussed is MGMT; the disease is gastric carcinoma.